Table 2.
Association of MMP9 serum levels with treatment response.
| Serum MMP9 | CR+PR Median (25-75%) (ng/ml) |
SD+PD Median (25-75%) (ng/ml) |
OR (95% CI) | P | OR (95% CI) adj | P adj |
|---|---|---|---|---|---|---|
| Before treatment | 757.4 (546.1-1175.5) | 683.5 (483.4-1242.3) | 1.014 (0.938-1.095) | 0.728 | 1.032 (0.951-1.118) | 0.452 |
| After treatment | 449.3 (226.4-763.3) | 440.5 (269.2-640.3) | 1.036 (0.925-1.160) | 0.542 | 1.092 (0.983-1.236) | 0.164 |
| Change after treatment | -299.4 (-603.1 to -8.5) | -286.3 (-648.5 to -74.2) | 1.012 (0.925-1.107) | 0.797 | 1.020 (0.925-1.124) | 0.696 |
Odds ratios (ORs) calculated for an increase of MMP9 levels for 100 ng/ml. Adj: adjusted for C-reactive protein; CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.